4//SEC Filing
IDEXX LABORATORIES INC /DE 4
Accession 0001140361-16-075492
$IDXXCIK 0000874716operating
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 5:01 PM ET
Size
15.0 KB
Accession
0001140361-16-075492
Insider Transaction Report
Form 4
Williams Michael J
Corporate Vice President
Transactions
- Exercise/Conversion
Common Stock
2016-08-08$38.49/sh+42,698$1,643,446→ 84,665 total - Sale
Common Stock
2016-08-08$108.96/sh−28,128$3,064,838→ 56,537 total - Sale
Common Stock
2016-08-08$108.92/sh−21,432$2,334,453→ 41,967 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2016-08-08−42,698→ 0 totalExercise: $38.49Exp: 2018-05-31→ Common Stock (42,698 underlying) - Exercise/Conversion
Common Stock
2016-08-08$38.80/sh+21,432$831,454→ 63,399 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2016-08-08−21,432→ 0 totalExercise: $38.80Exp: 2018-02-13→ Common Stock (21,432 underlying)
Footnotes (6)
- [F1]Includes 76 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2016.
- [F2]Represents the weighted average sales price of the shares sold ranging from a low of $108.53 to a high of $109.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average sales price of the shares sold ranging from a low of $108.56 to a high of $109.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F4]Grant of option to buy 10,716 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five annual installments beginning on February 14, 2012, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F5]Grant of option to buy 21,439 shares of IDEXX Laboratories, Inc. common stock that became exercisable five annual installments beginning on June 1, 2012, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F6]Not applicable.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000874716
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 5:01 PM ET
- Size
- 15.0 KB